William “Bill” Jones brings over 30 years of health care industry experience to our Apogenics. Since 2004 as the CEO/ President of Apogenics, a leading healthcare consultancy specializing in commercialization of specialty drugs for Pharmaceutical companies. Bill and his team have actively advised most of the top pharmaceutical and biotechnology manufacturers on how to maximize the market potential for their products.
Bill was the President of US Bioservices, a specialty pharmacy division of AmerisourceBergen and Executive VP of Operations for MIMs (now Bioscrip) a PBM, mail order and specialty infusion company. As the President of Churchill Lee Consulting, Bill provided hands on consulting to large PBM’s and specialty pharmacy companies including AARP, Caremark, Accredo, Express Scripts, Stadtlanders, CVS and Medco Health.
While at Medco as Vice President/General manager, then as Sr. Vice President of Strategic Planning, the company grew from $25 million to $4.4 billion in sales prior to being sold to Merck for $6.6 billion dollars. Bill was a key member of the management team that managed and thrived in this high growth environment.
Bill has a wealth of industry knowledge and experience, working on the payer side, in specialty pharmacy and consulting with large Pharma bringing real world perspective to Apogenics.